SR

Srinivas Ramineni

Active Director Director DIN 02061777
DIN 02061777 First appointment Mar 1996 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Mar 1996
Shareholding value •••• Premium profile

About Srinivas Ramineni

Data last updated:

Srinivas Ramineni is a Director at Hindustan Therapeutics Private Limited (since 1996), Additional Director at Averx Drugs Private Limited (since 2024) and Additional Director at Indovet Life Sciences Private Limited (since 2023). The companies operate in Pharma, Manufacturing and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹65.45 Cr; the largest is Hindustan Therapeutics Private Limited at ₹54.08 Cr (FY 2025). Earlier, Srinivas Ramineni was a Director at Upi Polymers Private Limited (2012–2017) and Designated Partner at Map Industrial Projects Llp (2012–2017) and 1 more.

DIN 02061777
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 1996
Oldest Company Age 30 yrs
Largest company Hindustan Therapeutics Private Limited · ₹54.08 Cr (FY 2025)
Combined revenue ₹65.45 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Mar 19961996₹54.08 Cr (FY 2025)Active
Averx Drugs Private Limited U24100AP2014PTC095163
Additional Director29 Jan 20242014₹6.36 Cr (FY 2021)Active
Additional Director12 Jun 20232020₹5.02 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Upi Polymers Private Limited U25200AP2010PTC066639
Director05 Jan 20122010₹4.17 Cr (FY 2022)Active
Designated Partner06 Feb 20122011Active
Director01 Jun 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr. Ramineni Farmers Producer Company Limited
Hindustan Therapeutics Private Limited
Averx Drugs Private Limited
Indovet Life Sciences Private Limited
Premium access

Shareholding and investment profile for Srinivas Ramineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Ramineni

Srinivas Ramineni currently holds 3 directorships: Hindustan Therapeutics Private Limited (Director, since 18 Mar 1996, revenue ₹54.08 Cr (FY 2025)); Averx Drugs Private Limited (Additional Director, since 29 Jan 2024, revenue ₹6.36 Cr (FY 2021)); Indovet Life Sciences Private Limited (Additional Director, since 12 Jun 2023, revenue ₹5.02 Cr (FY 2025)).

Srinivas Ramineni was first appointed on 18 Mar 1996 as Director at Hindustan Therapeutics Private Limited. The most recent appointment on record is 29 Jan 2024 at Averx Drugs Private Limited.

The 3 current companies of Srinivas Ramineni that report revenue have a combined latest revenue of ₹65.45 Cr: Hindustan Therapeutics Private Limited ₹54.08 Cr (FY 2025); Averx Drugs Private Limited ₹6.36 Cr (FY 2021); Indovet Life Sciences Private Limited ₹5.02 Cr (FY 2025).

Srinivas Ramineni held 3 earlier board appointments: Upi Polymers Private Limited (Director, 05 Jan 2012 to 10 Jun 2017); Map Industrial Projects Llp (Designated Partner, 06 Feb 2012 to 23 Mar 2017); Dr. Ramineni Farmers Producer Company Limited (Director, from 01 Jun 2021).

The current boards of Srinivas Ramineni's companies include Dharma Pracharak Ramineni (Hindustan Therapeutics Private Limited), Hanumantha Rao Ratakonda (Hindustan Therapeutics Private Limited), Veda Charya Chowdary Ramineni (Hindustan Therapeutics Private Limited), Dhana Lakshmi Tirupathi (Averx Drugs Private Limited), Nagasekhar Ramineni (Averx Drugs Private Limited), Vns Gopal Raju Kurapati (Averx Drugs Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available